Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Percheron Therapeutics ( (AU:PER) ) just unveiled an update.
Percheron Therapeutics Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, indicating a commitment to transparency and accountability in its governance practices. This announcement is significant for stakeholders as it reinforces the company’s dedication to maintaining high governance standards, potentially enhancing investor confidence and market reputation.
The most recent analyst rating on (AU:PER) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Percheron Therapeutics stock, see the AU:PER Stock Forecast page.
More about Percheron Therapeutics
Average Trading Volume: 3,569,710
Technical Sentiment Signal: Sell
Current Market Cap: A$11.42M
See more data about PER stock on TipRanks’ Stock Analysis page.